Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

626 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Semiconductor diode laser device adjuvanting intradermal vaccine.
Kimizuka Y, Callahan JJ, Huang Z, Morse K, Katagiri W, Shigeta A, Bronson R, Takeuchi S, Shimaoka Y, Chan MPK, Zeng Y, Li B, Chen H, Tan RYY, Dwyer C, Mulley T, Leblanc P, Goudie C, Gelfand J, Tsukada K, Brauns T, Poznansky MC, Bean D, Kashiwagi S. Kimizuka Y, et al. Among authors: gelfand j. Vaccine. 2017 Apr 25;35(18):2404-2412. doi: 10.1016/j.vaccine.2017.03.036. Epub 2017 Mar 30. Vaccine. 2017. PMID: 28365253 Free PMC article.
Near-infrared laser adjuvant for influenza vaccine.
Kashiwagi S, Yuan J, Forbes B, Hibert ML, Lee EL, Whicher L, Goudie C, Yang Y, Chen T, Edelblute B, Collette B, Edington L, Trussler J, Nezivar J, Leblanc P, Bronson R, Tsukada K, Suematsu M, Dover J, Brauns T, Gelfand J, Poznansky MC. Kashiwagi S, et al. Among authors: gelfand j. PLoS One. 2013 Dec 11;8(12):e82899. doi: 10.1371/journal.pone.0082899. eCollection 2013. PLoS One. 2013. PMID: 24349390 Free PMC article.
Laser vaccine adjuvants. History, progress, and potential.
Kashiwagi S, Brauns T, Gelfand J, Poznansky MC. Kashiwagi S, et al. Among authors: gelfand j. Hum Vaccin Immunother. 2014;10(7):1892-907. doi: 10.4161/hv.28840. Hum Vaccin Immunother. 2014. PMID: 25424797 Free PMC article. Review.
Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.
Morse K, Kimizuka Y, Chan MPK, Shibata M, Shimaoka Y, Takeuchi S, Forbes B, Nirschl C, Li B, Zeng Y, Bronson RT, Katagiri W, Shigeta A, Sîrbulescu RF, Chen H, Tan RYY, Tsukada K, Brauns T, Gelfand J, Sluder A, Locascio JJ, Poznansky MC, Anandasabapathy N, Kashiwagi S. Morse K, et al. Among authors: gelfand j. J Immunol. 2017 Aug 15;199(4):1319-1332. doi: 10.4049/jimmunol.1601873. Epub 2017 Jul 14. J Immunol. 2017. PMID: 28710250 Free PMC article.
Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response.
Kimizuka Y, Katagiri W, Locascio JJ, Shigeta A, Sasaki Y, Shibata M, Morse K, Sîrbulescu RF, Miyatake M, Reeves P, Suematsu M, Gelfand J, Brauns T, Poznansky MC, Tsukada K, Kashiwagi S. Kimizuka Y, et al. Among authors: gelfand j. J Immunol. 2018 Dec 15;201(12):3587-3603. doi: 10.4049/jimmunol.1701687. Epub 2018 Nov 12. J Immunol. 2018. PMID: 30420435 Free PMC article.
A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking.
Gelfand JA, Nazarian RM, Kashiwagi S, Brauns T, Martin B, Kimizuka Y, Korek S, Botvinick E, Elkins K, Thomas L, Locascio J, Parry B, Kelly KM, Poznansky MC. Gelfand JA, et al. FASEB J. 2019 Feb;33(2):3074-3081. doi: 10.1096/fj.201801095R. Epub 2018 Sep 7. FASEB J. 2019. PMID: 30192655 Free PMC article. Clinical Trial.
In this trial we demonstrated a maximum tolerable energy dose of 300 J/cm(2) to a spot on the lower back. The irradiated spot was biopsied 4 h later, as was a control spot. ...The laser adjuvant is a safe, well-tolerated adjuvant for i.d. vaccination in humans and results …
In this trial we demonstrated a maximum tolerable energy dose of 300 J/cm(2) to a spot on the lower back. The irradiated spot was bio …
A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.
Yuan J, Kashiwagi S, Reeves P, Nezivar J, Yang Y, Arrifin NH, Nguyen M, Jean-Mary G, Tong X, Uppal P, Korochkina S, Forbes B, Chen T, Righi E, Bronson R, Chen H, Orsulic S, Brauns T, Leblanc P, Scholler N, Dranoff G, Gelfand J, Poznansky MC. Yuan J, et al. Among authors: gelfand j. J Hematol Oncol. 2014 Feb 24;7:15. doi: 10.1186/1756-8722-7-15. J Hematol Oncol. 2014. PMID: 24565018 Free PMC article.
VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.
Leblanc P, Moise L, Luza C, Chantaralawan K, Lezeau L, Yuan J, Field M, Richer D, Boyle C, Martin WD, Fishman JB, Berg EA, Baker D, Zeigler B, Mais DE, Taylor W, Coleman R, Warren HS, Gelfand JA, De Groot AS, Brauns T, Poznansky MC. Leblanc P, et al. Among authors: gelfand ja. Hum Vaccin Immunother. 2014;10(10):3022-38. doi: 10.4161/hv.34413. Hum Vaccin Immunother. 2014. PMID: 25483693 Free PMC article. Review.
626 results